bioStrategies Study Presented at 2008 ACR Conference
FOR IMMEDIATE RELEASE
Chicago, IL — November 14, 2008
bioStrategies Group study presented at the 2008 American College of Rheumatology (ACR) Annual Scientific Meeting.
UCB (http://www.ucb-group.com) commissioned bioStrategies Group to conduct one of the largest ever market segmentation studies comprised of 2,000+ patients, 400 rheumatologists, and 101 nurses in the US. bioStrategies Group developed a unique and innovative approach linking rheumatologists and patients to uncover their differences in attitudes, perceptions and behaviors relative to treating rheumatoid arthritis. This unique approach provides UCB's marketing and sales teams with valuable insights as they prepare to launch Cimzia for treating rheumatoid arthritis in the US. For more information about the study, please contact Mike Kaestle or Matt Kowal.